Clinical Trials
6 trialsNCT04848519 2026-02-19
Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma
Emory University
Phase 2 Active not recruiting
NCT03152786 2025-02-17
Propranolol Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery
Wake Forest University Health Sciences
Phase 2 Terminated
NCT05679193 2024-05-29
PeP-RALP
Oslo University Hospital
Phase 2 Completed
NCT04493489 2020-07-30
Propranolol Adjuvant Treatment of Bladder Cancer
Central South University
Phase 2 Unknown
NCT03323710 2019-01-09
Study of Propranolol Plus Sunitinib in First-line Treatment of Metastatic Renal Cell Carcinoma
Military Institute od Medicine National Research Institute
Phase 2 Withdrawn
NCT01857817 2018-04-26
Efficacy and Safety Study of Etodolac and Propranolol in Patients With Clinically Progressive Prostate Cancer
Vicus Therapeutics
Phase 2 Terminated